Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2466
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis ; volume:21 ; number:1 ; day:10 ; month:7 ; year:2021 ; pages:1-10 ; date:12.2021
BMC pulmonary medicine ; 21, Heft 1 (10.7.2021), 1-10, 12.2021

Creator
Sugino, Keishi
Ono, Hirotaka
Watanabe, Natsumi
Ando, Masahiro
Tsuboi, Eiyasu
Homma, Sakae
Kishi, Kazuma
Contributor
SpringerLink (Online service)

DOI
10.1186/s12890-021-01595-3
URN
urn:nbn:de:101:1-2021101619103846410075
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:34 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Sugino, Keishi
  • Ono, Hirotaka
  • Watanabe, Natsumi
  • Ando, Masahiro
  • Tsuboi, Eiyasu
  • Homma, Sakae
  • Kishi, Kazuma
  • SpringerLink (Online service)

Other Objects (12)

Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat

Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat

Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications

Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications

Idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis

Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series

Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series

Real-World Clinical Efficacy of Antifibrotic Agents for Idiopathic Pulmonary Fibrosis: A Single-Center Retrospective Study in Japan

Real-World Clinical Efficacy of Antifibrotic Agents for Idiopathic Pulmonary Fibrosis: A Single-Center Retrospective Study in Japan

Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients

Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients

Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis

Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis

Pulmonary hypertension in idiopathic pulmonary fibrosis

Pulmonary hypertension in idiopathic pulmonary fibrosis

Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity

Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity

Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis

Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis

Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment

Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment

Related objects